Discussion

ESC Premium Access

Discussion

Session: Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)

Topic: Treatment

Speaker: Doctor M. Bonaca (Aurora, US) Professor H. Darius (Berlin, DE) Professor K. Ray (London, GB) Professor P. Steg (Paris, FR)

Supported by an unrestricted educational grant from AstraZeneca

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speakers

Doctor Marc Bonaca

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

30 presentations

1 follower

Professor Harald Darius

Vivantes Neukoelln Medical Center, Berlin (Germany)

11 presentations

0 follower

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

91 presentations

16 followers

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

66 presentations

10 followers

5 more presentations in this session

Welcome and introduction

Speaker: Professor P. Steg (Paris, FR)

Access

The prothrombotic nature of diabetes

Speaker: Professor K. Ray (London, GB)

Access

Slides

Video

Current practice of dual antiplatelet therapy in patients with diabetes

Speaker: Professor H. Darius (Berlin, DE)

Access

Slides

Video

Recent data and future direction on dual antiplatelet therapy in patients with diabetes

Speaker: Professor P. Steg (Paris, FR)

Access

Summary and close

Speaker: Doctor M. Bonaca (Aurora, US)

Access

Access the full session

Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)

Speakers: Doctor M. Bonaca, Professor H. Darius, Professor K. Ray, Professor P. Steg, Professor P. Steg...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources